ClinicalTrials.gg
Drug

Albendazole clinical trials

Also written Zentel.

studies test it
76
open now
5
in phase 3
16
first study started
1994

How each study uses Albendazole is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Albendazole studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
11 Jun 1996 · ALBENZA · NDA 020666 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Albendazole
49
Albendazole 400 mg
2
Mebendazole
2
Alb
2
Albendazole 400mg
2

Brand

Zentel
9
Albenza
1

In one entry with another drug

Given together, or one or the other

Albendazole and praziquantel
3
Albendazole and Ivermectin
2
Ivermectin + albendazole
2

Studies by the year they started

74 studies that test it; most in 2006 (7)

Studies that test Albendazole, by start year
YearStudies
19941
20002
20011
20051
20067
20073
20082
20096
20105
20111
20125
20132
20147
20152
20163
20174
20183
20192
20201
20213
20225
20231
20244
20252
20261

By phase

A phase 1/2 study counts in both.

Phase 1
2
Phase 2
12
Phase 3
16
Phase 4
17
No phase
31

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 4 · Other 72

Washington University School of Medicine (5) · National Institute of Allergy and Infectious Diseases (NIAID) (5) · Jennifer Keiser (4) · DBL -Institute for Health Research and Development (4) · University of Washington (3) · London School of Hygiene and Tropical Medicine (3) · International Centre for Diarrhoeal Disease Research, Bangladesh (3) · GlaxoSmithKline (2)

Often tested with

Tested in the same studies.

Ivermectin (13) · Praziquantel (9) · Moxidectin (4) · Azithromycin (4) · Zinc (4) · Diethylcarbamazine (3) · Mebendazole (3) · Pyrantel Pamoate (2)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 3, 1 in phase 3

Studies that test Albendazole, phase 3 first.

Studies

Open first, then newest update. How each study uses Albendazole is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 76

See all 76 studies that test Albendazole →

Given beside what is tested · 17 — Albendazole is usual care or a partner of the new treatment
As the comparator · 11 — what is tested is compared with Albendazole

Codes

What other systems call Albendazole · ClinicalTrials.gg INT008497

  • MeSH (NLM) D015766AlbendazoleConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) F4216019LNALBENDAZOLEConfirmed FDA, NLM, Wikidata
  • RxNorm 430Confirmed FDA, Wikidata
  • Wikidata Q411629albendazolConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C47384AlbendazoleOne source FDA
  • DrugBank DB00518One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.